Industry
Medical - Pharmaceuticals
BIMI International Medical Inc., together with its subsidiaries, engages in the retail and wholesale distribution of medical devices, and pharmaceutical and other healthcare products in the People's Republic of China. The company operates in four segments: Wholesale Pharmaceuticals, Wholesale Medical Devices, Medical Services, and Retail Pharmacies. It distributes Stryker spinal products, Olympus endoscopes, imported imaging products, and diagnostic imaging equipment to drug stores, private clinics, pharmaceutical dealers, and hospitals in the Southwest region of the People's Republic of China. The company also distributes generic drugs, Chinese herbal medicine, biochemical drugs, raw ingredients for pharmaceutical products, antibiotics, cardiovascular drugs, and anti-obesity medicines. In addition, it offers prescription and over-the-counter drugs, nutritional supplements, health foods, sundry products, traditional Chinese medicines, personal and family care products, medical devices, and miscellaneous items under the Lijiantang Pharmacy brand name. Further, the company provides medical services in the hospitals, as well as IT research and development services. It sells its medicine and other healthcare products to customers through its directly owned stores. The company was formerly known as BOQI International Medical Inc. and changed its name to BIMI International Medical Inc. in June 2021. BIMI International Medical Inc. was incorporated in 2000 and is based in Chongqing, the People's Republic of China.
Loading...
Open
0.01
Mkt cap
140K
Volume
141
High
0.01
P/E Ratio
N/A
52-wk high
4.13
Low
0.01
Div yield
N/A
52-wk low
0.01
Portfolio Pulse from Benzinga Newsdesk
April 23, 2024 | 8:39 pm
Portfolio Pulse from Benzinga Insights
April 23, 2024 | 4:31 pm
Portfolio Pulse from Benzinga Insights
April 18, 2024 | 8:31 pm
Portfolio Pulse from Benzinga Insights
April 17, 2024 | 12:08 pm
Portfolio Pulse from Benzinga Newsdesk
April 02, 2024 | 12:12 pm
Portfolio Pulse from Benzinga Insights
March 25, 2024 | 9:32 pm
Portfolio Pulse from Benzinga Insights
March 05, 2024 | 1:09 pm
Portfolio Pulse from Benzinga Insights
January 22, 2024 | 5:31 pm
Portfolio Pulse from Benzinga Insights
January 03, 2024 | 9:31 pm
Portfolio Pulse from Benzinga Newsdesk
December 19, 2023 | 1:06 pm
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.